You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Fluticasone

Showing 26 - 50 of 895
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pulmonary Disease, Chronic Obstructive Trial (FF/UMEC/VI)

Not yet recruiting
  • Pulmonary Disease, Chronic Obstructive
  • (no location specified)
Sep 7, 2022

Asthma Trial (mometasone furoate combination MDI 200/10 mcg BID, mometasone furoate combination MDI 400/10 mcg BID,

Completed
Has Results
  • Asthma
  • mometasone furoate combination MDI 200/10 mcg BID
  • +3 more
  • (no location specified)
Feb 7, 2022

Compare Bioequivalence of Two Fluticasone Propionate 0.05%

Completed
  • Healthy
  • Fluticasone Propionate 0.05% Cream-Reference Product
  • Fluticasone Propionate 0.05% Cream-Test product
  • (no location specified)
Oct 8, 2021

Compare Bioavailability of Two Fluticasone Propionate 0.005%

Completed
  • Healthy
  • Fluticasone Propionate 0.005% Ointment-Reference Product
  • Fluticasone Propionate 0.005% Ointment-Test product
  • (no location specified)
Oct 7, 2021

Asthma, Bioequivalence Trial in Larissa (Fluticasone Propionate 250 mcg/Blister Oral Inhalation Powder/Respirent

Active, not recruiting
  • Asthma
  • Bioequivalence
  • Fluticasone Propionate 250 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals
  • FLOVENT DISKUS
  • Larissa, Thessaly, Greece
    BECRO Clinical Facility
May 25, 2022

Allergic Rhinitis Trial in Cologne (Azelastine, Fluticasone, Azelastine mono, Azelastine)

Completed
  • Allergic Rhinitis
  • Azelastine, Fluticasone
  • +2 more
  • Cologne, NRW, Germany
    ClinPharmCologne
Feb 4, 2022

Asthma Trial in Raleigh, Edmond, San Antonio (Treatment A: Fp MDPI, Treatment B: FS MDPI, Treatment C Flovent)

Completed
  • Asthma
  • Treatment A: Fp MDPI
  • +3 more
  • Raleigh, North Carolina
  • +2 more
Nov 6, 2021

Eosinophilic Esophagitis Trial in Camarillo, Bozeman (APT-1011 3 mg HS)

Available
  • Eosinophilic Esophagitis
  • APT-1011 3 mg HS
  • Camarillo, California
  • +1 more
Jun 15, 2022

Asthma Trial (mometasone furoate dry powder inhaler, fluticasone propionate hydrofluoroalkane (HFA), montelukast)

Completed
Has Results
  • Asthma
  • mometasone furoate dry powder inhaler
  • +2 more
  • (no location specified)
Feb 7, 2022

Asthma Trial in Huntington Beach, Raleigh, San Antonio (Fluticasone Propionate MDPI, Fluticasone Propionate/Salmeterol MDPI,

Completed
  • Asthma
  • Fluticasone Propionate MDPI
  • +2 more
  • Huntington Beach, California
  • +2 more
Nov 5, 2021

Copd Trial in Assiut (SABA SAMA ICS Vs LABA LAMA ICs)

Not yet recruiting
  • Copd
  • SABA SAMA ICS Vs LABA LAMA ICs
  • Assiut, Egypt
    Nermen Mohammed Abuelkassem
Feb 28, 2023

Rhinitis Allergic Trial (triamcinolone XRG5029, fluticasone)

Completed
  • Rhinitis Allergic
  • triamcinolone XRG5029
  • fluticasone
  • (no location specified)
Apr 22, 2022

Eosinophilic Esophagitis Trial in Indianapolis, Boston, Melbourne (APT-1011, Placebo oral tablet)

Completed
  • Eosinophilic Esophagitis
  • Indianapolis, Indiana
  • +2 more
Nov 13, 2022

Using US Medical and Pharmacy Claim Records to Compare Resource

Completed
  • Pulmonary Disease, Chronic Obstructive
  • Trelegy Ellipta
  • +3 more
  • Eden Prairie, Minnesota
    Optum
Mar 11, 2022

Asthma Trial in Miami Lakes (Fluticasone Propionate and Salmeterol Inhalation Powder, Placebo Inhalation Powder)

Completed
Has Results
  • Asthma
  • Fluticasone Propionate and Salmeterol Inhalation Powder
  • Placebo Inhalation Powder
  • Miami Lakes, Florida
    Study Site 101
Aug 31, 2021

Seasonal Allergic Rhinitis Trial in Mississauga (Treatment A (Dymista): Fixed drug combination of azelastine HCl and fluticasone

Completed
  • Seasonal Allergic Rhinitis
  • Treatment A (Dymista): Fixed drug combination of azelastine hydrochloride and fluticasone propionate nasal spray at Visit 3
  • +3 more
  • Mississauga, Ontario, Canada
    Cliantha Research
Feb 11, 2022

Allergic Rhinitis Trial in Wuhan (Fluticasone Nasal 50 Mcg/Inh Nasal Spray, Azelastine Nasal 140 Mcg/Inh Nasal Spray,

Not yet recruiting
  • Allergic Rhinitis
  • Fluticasone Nasal 50 Mcg/Inh Nasal Spray, Azelastine Nasal 140 Mcg/Inh Nasal Spray
  • Fluticasone Nasal 50 Mcg/Inh Nasal Spray
  • Wuhan, Hubei, China
    Tongji Hosptial affiliated to Tongji Medical college of Huazhong
Dec 4, 2022

Asthma Trial in Spartanburg (Fluticasone propionate pressurized metered dose inhaler, Flovent HFA pressurized metered dose

Completed
  • Asthma
  • Fluticasone propionate pressurized metered dose inhaler
  • +2 more
  • Spartanburg, South Carolina
    Site 1
Aug 31, 2021

Eosinophilic Esophagitis Trial in Cleveland (Fluticasone Propionate, Budesonide)

Recruiting
  • Eosinophilic Esophagitis
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center
Jul 1, 2022

Covid19 Trial in Ho Chi Minh City (Fluticasone Propionate)

Recruiting
  • Covid19
  • Fluticasone Propionate
  • Ho Chi Minh City, Vietnam
    University of Medicine and Pharmacy at Ho Chi Minh City
Sep 21, 2021

Bioequivalence, Asthma Trial in Larissa (Test, Reference)

Active, not recruiting
  • Bioequivalence
  • Asthma
  • Larissa, Thessaly, Greece
    BECRO Clinical Facility
Oct 19, 2021

Asthma Trial (Mometasone furoate/formoterol (MF/F) MDI, Fluticasone propionate/salmeterol (F/SC) DPI)

Completed
Has Results
  • Asthma
  • Mometasone furoate/formoterol (MF/F) MDI
  • Fluticasone propionate/salmeterol (F/SC) DPI
  • (no location specified)
Feb 7, 2022

COPD Trial in Mexico City (Fluticasone Furoate/Vilanterol 100/25 mcgs, Umeclidinium/Vilanterol 62.5/25 mcgs)

Completed
  • COPD
  • Fluticasone Furoate/Vilanterol 100/25 mcgs
  • Umeclidinium/Vilanterol 62.5/25 mcgs
  • Mexico City, Tlalpan, Mexico
    National Institute of Respiratory Diseases 'Ismael Cosío Villega
Apr 18, 2022

Allergic Rhinitis Trial (Montelukast Oral Tablet)

Not yet recruiting
  • Allergic Rhinitis
  • Montelukast Oral Tablet
  • (no location specified)
May 14, 2022

To Evaluate PSQ as Clinical Tool in the Decision Between Medical and Surgical Treatment for Adenotonsillar Hypertrophy, To

Recruiting
  • To Evaluate PSQ as Clinical Tool in the Decision Between Medical and Surgical Treatment for Adenotonsillar Hypertrophy
  • To Determine Clinical Response to Montelukast or Nasal Steroids Based on PSQ Results
  • Be'er Ya'aqov, Israel
    Assaf-Harofeh Medical Center
Dec 7, 2022